{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-029405","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2025-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.005071+00:00","generated_at":"2026-05-24T02:54:33.424834+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CEO Werner Cautreels retiring; Iain Dukes appointed Interim CEO effective March 31, 2025","bullets":["Werner Cautreels to retire as CEO effective upon filing 2024 10-K around March 31; remains on board and as special advisor.","Iain Dukes, Executive Chairman, appointed Interim CEO; continues as Chairman.","Cautreels receives $10,000 lump sum and $10,000/month consulting fee for one year as special advisor.","No compensation changes for Dukes yet; amendment to his offer letter expected soon.","Investor update call scheduled for March 31, 2025 at 10:00 AM ET to review pipeline progress."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-029405","json":"https://secwatch.observer/filing/0001104659-25-029405.json","markdown":"https://secwatch.observer/filing/0001104659-25-029405.md","text":"https://secwatch.observer/filing/0001104659-25-029405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925029405/0001104659-25-029405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925029405/tm2510819d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T02:54:33.424834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29151cecfc","claim":"Werner Cautreels resigned as Chief Executive Officer at Traws Pharma, Inc..","evidence_excerpt":"On March 28, 2025, Werner Cautreels notified Traws Pharma, Inc. (the Company”) of his decision to retire and resign from his role as Chief Executive Officer of the Company, effective as of the close of business on the day that the Company files its Annual Report on Form 10-K for its 2024 fiscal year","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925029405/0001104659-25-029405-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"3ee1479e1d","claim":"Iain Dukes was appointed as Interim Chief Executive Officer at Traws Pharma, Inc..","evidence_excerpt":"Effective as of the Termination Date, the Board appointed Iain Dukes to serve as the Company’s Interim Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925029405/0001104659-25-029405-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}